MYLK2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11574
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-KDTKNMEAKKLSKD corresponding to internal region according to NP_444253.3, NP_444254.3 , NP_444255.3, NP_444256.3.
Epitope
CKDTKNMEAKKLSKD
Specificity
This antibody is expected to recognise all reported isoforms (NP_444253.3; NP_444254.3 ; NP_444255.3 and NP_444256.3).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for MYLK2 Antibody
Western Blot: MYLK2 Antibody [NBP2-11574]
Western Blot: MYLK2 Antibody [NBP2-11574] - (0.03ug/ml) staining of Human Colon lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for MYLK2 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:8000
Western Blot
0.01 - 0.03 ug/ml
Application Notes
WB: Approx. 150 kDa band observed in human colon and lung lysates (calculated MW of 197 kDa band according to NP_444256.3).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: MYLK2
Long Name
Myosin light chain kinase 2, skeletal/cardiac muscle
Alternate Names
EC 2.7.11.18, MLCK2
Entrez Gene IDs
4638 (Human)
Gene Symbol
MYLK
Additional MYLK2 Products
Product Documents for MYLK2 Antibody
Product Specific Notices for MYLK2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...